Brinker Capital Investments, LLC Ardelyx, Inc. Transaction History
Brinker Capital Investments, LLC
- $5.01 Billion
- Q4 2022
Shares
3 transactions
Others Institutions Holding ARDX
# of Institutions
209Shares Held
144MCall Options Held
1.01MPut Options Held
1.43M-
Janus Henderson Group PLC London, X025.9MShares$167 Million0.11% of portfolio
-
Black Rock Inc. New York, NY17.6MShares$113 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.7MShares$87.8 Million0.0% of portfolio
-
State Street Corp Boston, MA12MShares$76.9 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C36.9MShares$44.4 Million0.06% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $994M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...